Inozyme Pharma, Inc. (INZY)
NASDAQ: INZY · Real-Time Price · USD
5.81
-0.02 (-0.34%)
At close: Sep 18, 2024, 4:00 PM
5.65
-0.16 (-2.73%)
After-hours: Sep 18, 2024, 7:53 PM EDT

Inozyme Pharma Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018
Net Income
-88.56-71.17-67.06-56.62-56.42-19.72
Upgrade
Depreciation & Amortization
0.790.830.740.670.220.08
Upgrade
Loss (Gain) From Sale of Assets
0.020.020.02---
Upgrade
Asset Writedown & Restructuring Costs
----17.76-
Upgrade
Loss (Gain) From Sale of Investments
-7.27-5.44-1.670.170.28-0.07
Upgrade
Stock-Based Compensation
7.197.047.677.162.310.3
Upgrade
Other Operating Activities
1.481.120.530.38--
Upgrade
Change in Accounts Payable
1.51-1.380.15-0.682.1-0.08
Upgrade
Change in Other Net Operating Assets
-0.71-1.71.860.76-2.210.68
Upgrade
Operating Cash Flow
-85.55-70.68-57.76-48.15-35.97-18.81
Upgrade
Capital Expenditures
-0.14-0.3-0.41-0.4-0.57-0.14
Upgrade
Investment in Securities
-22.73-53.35-4.9943.19-116.61-8.25
Upgrade
Investing Cash Flow
-22.88-53.65-5.442.8-117.18-8.39
Upgrade
Long-Term Debt Issued
-404.05---
Upgrade
Net Debt Issued (Repaid)
12.5404.05---
Upgrade
Issuance of Common Stock
70.3585.9768.740.61116.170.07
Upgrade
Financing Cash Flow
82.85125.9772.790.61149.8122.97
Upgrade
Foreign Exchange Rate Adjustments
-0.04-0.02-0.030.02--
Upgrade
Net Cash Flow
-25.611.639.6-4.72-3.34-4.23
Upgrade
Free Cash Flow
-85.69-70.97-58.17-48.55-36.54-18.95
Upgrade
Free Cash Flow Per Share
-1.41-1.37-1.54-2.06-3.31-16.02
Upgrade
Cash Interest Paid
2.352.350.17---
Upgrade
Levered Free Cash Flow
-55.05-46.05-32.07-27.29-29.91-12.14
Upgrade
Unlevered Free Cash Flow
-51.96-43.96-31.9-27.29-29.91-12.14
Upgrade
Change in Net Working Capital
1.744.26-3.01-0.67-3.78-0.62
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.